Given the mounting evidence for the role of ANGPTL-3 and ANGPTL-4 in cancer [36,40], perhaps the hepatic microenvironment shaped by advanced fibrosis in F3 HCV patients could be the one that dictates the depth of ANGPTLs’ involvement in HCC development. The gene discussed is ANGPTL3; the disease is hepatocellular carcinoma.